Skip to main content
. 2023 Nov 11;16:3251–3266. doi: 10.2147/CCID.S435795

Table 1.

Demographic Characteristics of the Subjects

Group A (VISPO oral) N = 18 Group B (Placebo oral) N = 19 Group C (VISPO Topical) N = 18 Group D (Placebo Topical) N = 18 p-value (A vs B) p-value (C vs D)
Sex Male, n (%) 14 (70) 14 (70) 16 (80) 16 (80) 1.000# 1.000#
Female, n (%) 6 (30) 6 (30) 4 (20) 4 (20)
Age (y) 35.10±6.03 36.45±6.01 34.05±7.07 35.85±6.28 0.483 0.399
Height (cm) 166.40±10.19 165.55±8.12 169.05±8.11 170.60±8.71 0.708 0.134
Weight (kg) 67.06±9.90 68.23±9.65 68.19±10.91 73.31±10.22 0.772 0.564
BMI (kg/m2) 24.20±2.67 24.82±2.48 23.76±2.74 25.13±2.38 0.452 0.101

Notes: The values are presented as the mean ± standard deviation. #Chi-square test; Unpaired t-test.